Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Glaxo Wellcome and SmithKline Beecham announced their merger on January 18, 2000, creating the largest drug company in the world with global drug sales of GBP…
The formation of GlaxoSmithKline through the merger of Glaxo Wellcome and SmithKline Beecham in 2000 created a pharmaceutical powerhouse with combined global…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Glaxo Wellcome and SmithKline Beecham announced their merger in January 2000, combining to form GlaxoSmithKline (GSK). The merger created the world's largest pharmaceutical company at the time of its formation, with combined global revenues exceeding $25 billion. GSK did not acquire SmithKline Beecham; it was the entity created by the merger.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| GSK plc / SmithKline Beecham (this deal) | 2000 | $12.0B | 79 |
| GSK plc / Pfizer Inc. | 2018 | $0.0M | 77 |
| GSK plc / Novartis AG | 2014 | $16.0B | 76 |
| GSK plc / Hansoh Pharmaceutical Group Co. Ltd. | 2023 | $1.7B | 74 |
| GSK plc / Nuvalent, Inc. | 2026 | $10.6B | 70 |
| GSK plc / Sierra Oncology Inc. | 2022 | $1.9B | 70 |
| GSK plc / Human Genome Sciences | 2012 | $3.6B | 70 |
← Browse all deals · How we score deals
More: 2000 deals · GSK plc deals · Infectious Disease deals